Virtual Pain Care for High Risk Veterans on Opioids During COVID19 (and Beyond)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 44
- 试验地点
- 4
- 主要终点
- The Number of Patients Who Agree to Change in Their Opioid Regimen, Including Buprenorphine Transfer
研究概览
简要总结
The COVID-19 pandemic is exacerbating the challenges faced by Veterans at risk of opioid overdose including Veterans prescribed moderate-to-high dose long-term opioid therapy (LTOT) whose usual treatment resources and coping strategies may be inaccessible. This project combines established VA care components to deploy and evaluate virtual models of care for Veterans on high-risk LTOT to meet the dual challenges of maintaining social distancing and delivery high quality care.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Eligible participants must currently receive LTOT for chronic pain at 50 mg morphine equivalent daily dose
排除标准
- •Exclusion criteria at baseline are:
- •dementia diagnosis or moderate-severe cognitive impairment
- •unstable or severe untreated psychiatric disorder or medical disease that requires hospitalization
- •documentation of suspected controlled substance diversion
- •inability to communicate by phone
结局指标
主要结局
The Number of Patients Who Agree to Change in Their Opioid Regimen, Including Buprenorphine Transfer
时间窗: 30 days
Using shared decision-making with Veterans, we will based the measure on clinical reports of patient change in opioid regimen. This would be tapering (reducing opioid dose), discontinuation, or transfer to buprenorphine. Any reduction or change was considered positive for change, even if the patients returned to their initial dose. The number of patients who agree to change their opioid regimen provides a realistic indicator of overall feasibility/acceptability.
次要结局
- Number of Participants Retained in Care at End of Study(60 days)